Bellicum Pharmaceuticals (BLCM) Q4 2022 Earnings

31MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.93
-0.66
-0.4
-0.13

Details

Expected EPS
-0.93
Actual EPS
-0.2
Surprise EPS
0.73
Surprise Percent
+78.49%

Description

Bellicum Pharmaceuticals (BLCM) has reported earnings of -0.2 per share for Q4 2022.

0 Comments

Share your thoughts